Early administration of pegfilgrastim contributes to the safety of DCF therapy as neoadjuvant chemotherapy for esophageal cancer

被引：0
|
作者：
Morita, Ryuichi [1 ]
Ishikawa, Takeshi [1 ,2 ]
Endo, Yuki [1 ]
Yasuda, Takeshi [1 ]
Oka, Kaname [1 ]
Sakakida, Tomoki [1 ]
Matsumura, Shinya [1 ]
Mizushima, Katsura [1 ]
Doi, Toshifumi [1 ]
Okayama, Tetsuya [1 ]
Katada, Kazuhiro [1 ]
Kamada, Kazuhiro [1 ]
Uchiyama, Kazuhiko [1 ]
Takagi, Tomohisa [1 ]
Fujiwara, Hitoshi [3 ]
Konishi, Hideyuki [1 ]
Itoh, Yoshito [1 ]
机构：
[1] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Mol Gastroenterol & Hepatol, Kyoto, Japan
[2] Kyoto Prefectural Univ Med, Univ Hosp, Outpatient Oncol Unit, Kyoto, Japan
[3] Grad Sch Med Sci, Div Digest Surg, Dept Surg, Kyoto, Japan
来源：
ANNALS OF ONCOLOGY | 2023年 / 34卷
关键词：
D O I：
10.1016/j.annonc.2023.09.258
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MO40-5
引用
下载
收藏
页码：S1422 / S1422
页数：1
相关论文
共 50 条
  • [21] Early administration of pegfilgrastim for esophageal cancer treated with docetaxel, cisplatin, and fluorouracil: A phase II study
    Ishikawa, Takeshi
    Yasuda, Tomoyo
    Okayama, Tetsuya
    Dohi, Osamu
    Yoshida, Naohisa
    Kamada, Kazuhiro
    Uchiyama, Kazuhiko
    Takagi, Tomohisa
    Konishi, Hirotaka
    Shiozaki, Atsushi
    Fujiwara, Hitoshi
    Konishi, Hideyuki
    Naito, Yuji
    Teramukai, Satoshi
    Itoh, Yoshito
    CANCER SCIENCE, 2019, 110 (12) : 3754 - 3760
  • [22] Neoadjuvant therapy of esophageal cancer
    Kelsen, DP
    CANCER JOURNAL FROM SCIENTIFIC AMERICAN, 1997, 3 (03): : 137 - 139
  • [23] Neoadjuvant DCF in resectable esophageal cancer: Single-center experience
    Noronha, Vanita
    Gulia, Seema
    Joshi, Amit
    Prabhash, Kumar
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [24] Aortitis and aortic dissection after administration of pegfilgrastim during adjuvant chemotherapy for early breast cancer
    Shiraki, Eriko
    Hamada-Nishimoto, Mai
    Kang, Yookija
    Tsuyuki, Shigeru
    INTERNATIONAL CANCER CONFERENCE JOURNAL, 2022, 11 (02) : 138 - 141
  • [25] Aortitis and aortic dissection after administration of pegfilgrastim during adjuvant chemotherapy for early breast cancer
    Eriko Shiraki
    Mai Hamada-Nishimoto
    Yookija Kang
    Shigeru Tsuyuki
    International Cancer Conference Journal, 2022, 11 : 138 - 141
  • [26] Prediction of the neoadjuvant chemotherapy for esophageal cancer by the IgG
    Nakaya, Seiichi
    Ishiguro, Hideyuki
    Samoto, Yosuke
    Okubo, Tomotaka
    Sagawa, Hiroyuki
    Tanaka, Tatsuya
    Ogawa, Ryo
    Takahashi, Hiroki
    Matsuo, Yoichi
    Takiguchi, Shuji
    CANCER SCIENCE, 2018, 109 : 471 - 471
  • [27] Neoadjuvant chemotherapy (FAP) for advanced esophageal cancer
    Shimakawa, Takeshi
    Naritaka, Yoshihiko
    Asaka, Shinichi
    Isohata, Noriyuki
    Murayama, Minoru
    Konno, Soichi
    Yoshimatsu, Kazuhiko
    Shiozawa, Shunichi
    Katsube, Takao
    Ogawa, Kenji
    ANTICANCER RESEARCH, 2008, 28 (4C) : 2321 - 2326
  • [28] Correlation Between Histopathological Response of Esophageal Squamous Cell Carcinoma to Neoadjuvant DCF Therapy and the Clinical Efficacy of Palliative Chemotherapy for Recurrence
    Shota Igaue
    Shun Yamamoto
    Kazuhiro Shiraishi
    Mai Itoyama
    Hiroshi Imazeki
    Kazuki Yokoyama
    Yoshitaka Honma
    Tairo Kashihara
    Daisuke Kurita
    Koshiro Ishiyama
    Junya Oguma
    Hiroyuki Daiko
    Ken Kato
    Journal of Gastrointestinal Cancer, 2025, 56 (1)
  • [29] Safety and efficacy of pegfilgrastim in children with cancer receiving myelosuppressive chemotherapy
    Andre, Nicolas
    El Kababri, Maria
    Bertrand, Pourroy
    Rome, Angelique
    Coze, Carole
    Gentet, Jean Claude
    Bernard, Jean Louis
    ANTI-CANCER DRUGS, 2007, 18 (03) : 277 - 281
  • [30] Neoadjuvant and adjuvant therapy in esophageal cancer
    Weiss, Jennifer A.
    Jain, Shikha
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2023, 14 (04) : 1919 - 1932
12345